Company / Net Income
Organon & Co. Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$187.0M
FY2025
5-year range
$187.0M / $3.2B
FY2021-FY2025
Trend
-78.4%
vs FY2024
Sector context
#37 of 216
Health Care
What the data says
Organon & Co.'s net income of $187M is higher than 83% of companies in the Health Care sector (FY2025). Net Income has fluctuated over the past 7 years, ranging from $187M in FY2025 to $3.2B in FY2021.
Based on SEC 10-K filings.
$187M in FY2025 with a 5-year CAGR of -38.7%. Top quartile in the Health Care sector.
Declined from $1.0B to $187M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -41.1%
- 5-Year CAGR
- -38.7%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 216This company $187.0M Sector average $454.1M
▼
-58.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -38.7%, indicating a declining trend.
- In FY2025, net income decreased 78.4% year-over-year.
- Ranks #37 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 55.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $187.0M | -78.4% |
| FY2024 | $864.0M | -15.5% |
| FY2023 | $1.0B | +11.6% |
| FY2022 | $917.0M | -71.5% |
| FY2021 | $3.2B | +49.0% |
| FY2020 | $2.2B | -32.9% |
| FY2019 | $3.2B | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026